$FENC: Short setup
Updated
FENC has a nice short signal, the stock had a spectacular rally since it bottomed in early 2022, but could be reaching the end of the road here after drastically outperforming the market until now. Their drug received FDA approval in Sep 2022, commercial availability in the US in Oct 2022, but despite this, the latest report showed an increase in net loss YoY (twice as much as reported on Q3 2021). Seems like a decent short here, after this impressive run. Stop @ 9.95, support @ 8.Best of luck!
Cheers,
Ivan Labrie.
Comment
Off to a good start.
Trade closed: stop reached
🔒Want to dive deeper? Check out my paid services below🔒
ivanlabrie.substack.com/
ivanlabrie.substack.com/
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.